PortfoliosLab logoPortfoliosLab logo
TGTX vs. ASM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TGTX vs. ASM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TG Therapeutics, Inc. (TGTX) and Avino Silver & Gold Mines Ltd. (ASM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TGTX achieves a 66.12% return, which is significantly higher than ASM's 2.90% return. Over the past 10 years, TGTX has outperformed ASM with an annualized return of 21.61%, while ASM has yielded a comparatively lower 11.05% annualized return.


TGTX

1D
3.06%
1M
16.11%
YTD
66.12%
6M
57.96%
1Y
32.51%
3Y*
21.69%
5Y*
5.57%
10Y*
21.61%

ASM

1D
6.86%
1M
-18.39%
YTD
2.90%
6M
7.58%
1Y
72.24%
3Y*
109.07%
5Y*
37.29%
10Y*
11.05%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TGTX vs. ASM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TGTX
TG Therapeutics, Inc.
66.12%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%
ASM
Avino Silver & Gold Mines Ltd.
2.90%604.88%68.13%-22.95%-21.01%-33.77%124.14%-4.92%-54.48%-2.19%

Correlation

The correlation between TGTX and ASM is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.08

The correlation between TGTX and ASM shifts across timeframes, from 0.08 (all time) to 0.19 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TGTX:

$7.93B

ASM:

$1.11B

EPS

TGTX:

$2.87

ASM:

$0.23

PE Ratio

TGTX:

17.23

ASM:

28.13

PEG Ratio

TGTX:

0.03

ASM:

0.08

PS Ratio

TGTX:

11.37

ASM:

9.37

PB Ratio

TGTX:

13.59

ASM:

4.02

Total Revenue (TTM)

TGTX:

$700.35M

ASM:

$110.70M

Gross Profit (TTM)

TGTX:

$581.54M

ASM:

$59.09M

EBITDA (TTM)

TGTX:

$156.88M

ASM:

$55.20M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TGTX vs. ASM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TGTX
TGTX Risk / Return Rank: 6363
Overall Rank
TGTX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6363
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6464
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6161
Martin Ratio Rank

ASM
ASM Risk / Return Rank: 6969
Overall Rank
ASM Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
ASM Sortino Ratio Rank: 7070
Sortino Ratio Rank
ASM Omega Ratio Rank: 6868
Omega Ratio Rank
ASM Calmar Ratio Rank: 6969
Calmar Ratio Rank
ASM Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TGTX vs. ASM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and Avino Silver & Gold Mines Ltd. (ASM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TGTXASMDifference
Sharpe ratioReturn per unit of total volatility

-0.19

Sortino ratioReturn per unit of downside risk

-0.31

Omega ratioGain probability vs. loss probability

1.16

1.20

-0.03

Calmar ratioReturn relative to maximum drawdown

1.00

1.39

-0.39

Martin ratioReturn relative to average drawdown

1.81

2.95

-1.14

TGTX vs. ASM - Sharpe Ratio Comparison

The current TGTX Sharpe Ratio is 0.69, which is comparable to the ASM Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of TGTX and ASM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TGTX vs. ASM - Drawdown Comparison

The maximum TGTX drawdown since its inception was -99.52%, which is greater than ASM's maximum drawdown of -94.10%. Use the drawdown chart below to compare losses from any high point for TGTX and ASM.


Loading charts...

Drawdown Indicators


TGTXASMDifference

Max Drawdown

Largest peak-to-trough decline

-99.52%

-94.10%

-5.42%

Max Drawdown (1Y)

Largest decline over 1 year

-32.66%

-52.40%

+19.74%

Max Drawdown (3Y)

Largest decline over 3 years

-75.42%

-52.40%

-23.02%

Max Drawdown (5Y)

Largest decline over 5 years

-90.75%

-68.51%

-22.24%

Max Drawdown (10Y)

Largest decline over 10 years

-93.19%

-90.91%

-2.28%

Current Drawdown

Current decline from peak

-78.79%

-43.15%

-35.64%

Average Drawdown

Average peak-to-trough decline

-91.43%

-63.76%

-27.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.04%

24.57%

-6.53%

Volatility

TGTX vs. ASM - Volatility Comparison

The current volatility for TG Therapeutics, Inc. (TGTX) is 15.65%, while Avino Silver & Gold Mines Ltd. (ASM) has a volatility of 26.77%. This indicates that TGTX experiences smaller price fluctuations and is considered to be less risky than ASM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TGTXASMDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.65%

26.77%

-11.12%

Volatility (6M)

Calculated over the trailing 6-month period

34.28%

65.36%

-31.08%

Volatility (1Y)

Calculated over the trailing 1-year period

47.22%

82.16%

-34.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.77%

66.03%

+21.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.88%

69.72%

+17.16%

Dividends

TGTX vs. ASM - Dividend Comparison

Neither TGTX nor ASM has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TGTX vs. ASM - Financials Comparison

This section allows you to compare key financial metrics between TG Therapeutics, Inc. and Avino Silver & Gold Mines Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20222023202420252026
204.92M
41.41M
(TGTX) Total Revenue
(ASM) Total Revenue
Values in USD except per share items

TGTX vs. ASM - Profitability Comparison

The chart below illustrates the profitability comparison between TG Therapeutics, Inc. and Avino Silver & Gold Mines Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
83.7%
61.6%
Portfolio components
TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

ASM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Avino Silver & Gold Mines Ltd. reported a gross profit of 25.51M and revenue of 41.41M. Therefore, the gross margin over that period was 61.6%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

ASM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Avino Silver & Gold Mines Ltd. reported an operating income of 21.76M and revenue of 41.41M, resulting in an operating margin of 52.5%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.

ASM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Avino Silver & Gold Mines Ltd. reported a net income of 15.69M and revenue of 41.41M, resulting in a net margin of 37.9%.


Frequently Asked Questions


TGTX and ASM have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASM has higher volatility (26.77%) compared to TGTX (15.65%). In terms of maximum drawdown, TGTX dropped -99.52% vs ASM's -94.10%.

ASM currently has the higher Sharpe Ratio (0.89 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TGTX and ASM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer